T.S. Jaishankar of Quest Lifesciences, Amar Reddy of Symphony Pharma Life Sciences, Dr. Hemanth Nandigala of Virchow Biotech, Dr. Shivprakash Rathnam of Novelgenix Therapeutics, Suresh Singla of Titan Biotech, Dr. Adrian Almeida of BioAzure Technologies in the race for the prestigious Pharma Leaders Most Promising & Innovative Biotech Leader of the Decade
T.S. Jaishankar of Quest Lifesciences, Amar Reddy of Symphony Pharma Life Sciences, Dr. Hemanth Nandigala of Virchow Biotech, Dr. Shivprakash Rathnam of Novelgenix Therapeutics, Suresh Singla of Titan Biotech, Dr. Adrian Almeida of BioAzure Technologies in the race for the prestigious Pharma Leaders Most Promising & Innovative Biotech Leader of the Decade
Pharma Leaders Most Promising & Innovative Biotech Leader of the Decade Nominees
1. Mr. T.S. Jaishankar, Managing Director, Quest Lifesciences Pvt. Ltd.
2. Mr. Amar Reddy,MD & Co-Founder,Symphony Pharma Life Sciences Private Limited
3. Dr. Hemanth Nandigala, MD, Virchow Biotech Private Limited
4. Dr. Shivprakash Rathnam,Founder Chairman and MD,Novelgenix Therapeutics Pvt. Ltd.
5. Mr.Suresh Singla,Managing Director, Titan Biotech ltd
6. Dr. Adrian Almeida,Managing Director, BioAzure Technologies Pvt. Ltd.
Voting Link : https://goo.gl/forms/tvNvUZZM4K5LVKB53
India is among the top 12 biotech destinations in the world and ranks third in the Asia Pacific.India has the second highest number of United States Food & Drug Administration(USFDA) approved plants.No.1 producer of Hepatitis B vaccine recombinant.Indian biotech industry shall touch USD 100 billion by 2025.Large consumer base with increasing disposable income. ndia is amongst the top 12 biotech destinations in the world and ranks third in the Asia Pacific region.India has the second highest number of U.S. Food and Drug Administration (USFDA)-approved plants, after the USA.India has adopted the product patent regime in 2005.Huge domestic market and Large consumer base with increasing disposable income.India is the world’s leading supplier of affordable vaccines and producer of recombinant Hepatitis B vaccine.India is the fastest growing major economies with GDP growth rate of above 7%.India has the potential to become a major producer of transgenic rice and several genetically modified (GM) or engineered vegetables.Abundance of highly-skilled and trained pool of talent.Special purpose organisation such as Biotechnology Industry Research Assistance Council (BIRAC), a Public Sector Undertaking of Department of Biotechnology, to suppose industry through funding, mentoring, handholding and infrastructure support. The Indian biotech industry is expected to grow at 30.46 percent CAGR to reach USD 100 billion by 2025.
However, Despite tremendous opportunities and progress, the Indian biotechnology sector does not get that much limelight and face several challenges. The biotechnology sector is still not that popular with students, parents and even investors in comparison to other sectors like financial services, software, e-commerce, data analytics etc. Here is a comprehensive post on the Indian biotechnology sector (with focus on biopharmaceutical segment) – opportunities, challenges, top companies, top startups, incubators and startup accelerators and venture capitals. The healthcare sector comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance and medical equipment. The Indian healthcare sector is growing at a brisk pace due to its strengthening coverage, services and increasing expenditure by public as well private players. The Indian healthcare sector is growing at 15% CAGR. FDI investment in hospital and diagnostic centers from 200 to 2015 was $3.21 billion. According to IBEF, the Indian healthcare market was worth $100 billion in 2015. It is expected to reach $280 billion by 2020 (thanks to the digital adoption), thus clocking a CAGR of 22.9%. In terms of revenue and employment, the healthcare sector is now one of the largest sectors in India.
The Biotechnology Industry in India has grown from $1.1 billion in 2005 to $7 billion in 2015 and is expected to reach $11.6 billion in 2017.The growth is due to a range of positive trends such as growing demand for healthcare services, increase demand for food & nutrition intensive R&D activities and strong government initiatives. The Indian biotech sector is divided into five major segments- bio-pharma, bio-services, bio-agri, bio-industrial and bio-informatics.
About Pharma Leaders Power Brand Awards
The Pharma Leaders Awards™ is an annual competition designed to honor excellence in the healthcare sector through a comprehensive methodology to motivate,boost & support the innovations & innovators in the healthcare industry giving the winners the recognition that often go unnoticed. Pharmaleaders has been at the forefront of highlighting the neglected & crucial issues confronted by the Healthcare Industry & bring them at the notice of the authorities. Widely perceived by the industry leaders as the voice & reflection of the indian healthcare industry, Pharmaleaders is present in print, digital & live seminars.
We embarked our Journey in the year 1999 while the healthcare Industry was fast emerging as a rising force though in a very unorganized way. We are the first to introduce meaningful dialogue amongst the professionals of the Pharmaceutical Industry in the form of Summit & Conclaves. We are also the first to introduce the healthcare awards known as Pharmaleaders Awards to recognize the shining stars of the indian healthcare industry.
An unbiased review by a network of industry experts, business executives and academics provides a 3rd-party validation that delivers a formation of superior quality —a confirmation that can reach customers in a way that marketing and advertising cannot. Receiving a Pharmaleaders Award—one of the most prestigious accolades honoring excellence in healthcare innovations —provides a powerful 3rd-party validation. Award winners gain broad national recognition and significant market visibility through the publicity their award generates. The annual event draws hundreds of fellow innovators into a nexus of powerful networking opportunities. Winners broadcast their award-winning status to the business media and promote their innovation to their audiences by using the Edison Awards seal. As companies ranging from startups to Fortune 500 feature the Pharma Leaders Awards Excellence Certificates, the brand Pharma Leaders makes millions of impressions worldwide.We are passionate about help building Pharma Leaders of tomorrow